Evidence map›Paper›PMID 36454022›Full record

ArticleNucleic acids research2022

Structural basis of transcription regulation by CNC family transcription factor, Nrf2.

Toru Sengoku, Masaaki Shiina, Kae Suzuki, Keisuke Hamada, Ko Sato, Akiko Uchiyama, Shunsuke Kobayashi, Asako Oguni, Hayato Itaya, Kota Kasahara and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Dissecting the Interplay Between NRF2 and BACH1 at CsMBEs.Antioxidants (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. HPPE Activates NRF2 Signaling by Liberating Heavy Metal Stores.Chembiochem : a European journal of chemical biology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Role of NRF2 in Pathogenesis of Alzheimer's Disease.Antioxidants (Basel, Switzerland) · 2024
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Toru SengokuDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.ORCID 0000-0001-9461-8714
Masaaki ShiinaDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Kae SuzukiDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Keisuke HamadaDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Ko SatoDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Akiko UchiyamaDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Shunsuke KobayashiDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Asako OguniDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Hayato ItayaCollege of Life Sciences, Ritsumeikan University, Kusatsu 525-8577, Japan.
Kota KasaharaCollege of Life Sciences, Ritsumeikan University, Kusatsu 525-8577, Japan.ORCID 0000-0003-0207-6271
Hirotomo MoriwakiRIKEN Center for Biosystems Dynamics Research, Yokohama 230-0045, Japan.
Chiduru WatanabeRIKEN Center for Biosystems Dynamics Research, Yokohama 230-0045, Japan.
Teruki HonmaRIKEN Center for Biosystems Dynamics Research, Yokohama 230-0045, Japan.
Chikako OkadaDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Shiho BabaDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Tsutomu OhtaDepartment of Physical Therapy, Faculty of Health and Medical Sciences, Tokoha University, Hamamatsu 431-2102, Japan.
Hozumi MotohashiDepartment of Gene Expression Regulation, Institute of Development, Aging, and Cancer, Tohoku University, Sendai 980-8575, Japan.ORCID 0000-0002-7261-1033
Masayuki YamamotoDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai 980-8575, Japan.
Kazuhiro OgataDepartment of Biochemistry, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
Yokohama City University · JPRIKEN Center for Biosystems Dynamics Research · JPRitsumeikan University · JPTohoku University · JPTokoha Gakuen University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several basic leucine zipper (bZIP) transcription factors have accessory motifs in their DNA-binding domains, such as the CNC motif of CNC family or the EHR motif of small Maf (sMaf) proteins. CNC family proteins heterodimerize with sMaf proteins to recognize CNC-sMaf binding DNA elements (CsMBEs) in competition with sMaf homodimers, but the functional role of the CNC motif remains elusive. In this study, we report the crystal structures of Nrf2/NFE2L2, a CNC family protein regulating anti-stress transcriptional responses, in a complex with MafG and CsMBE. The CNC motif restricts the conformations of crucial Arg residues in the basic region, which form extensive contact with the DNA backbone phosphates. Accordingly, the Nrf2-MafG heterodimer has approximately a 200-fold stronger affinity for CsMBE than canonical bZIP proteins, such as AP-1 proteins. The high DNA affinity of the CNC-sMaf heterodimer may allow it to compete with the sMaf homodimer on target genes without being perturbed by other low-affinity bZIP proteins with similar sequence specificity.

Indexed as

Gene Expression RegulationNF-E2-Related Factor 2Basic-Leucine Zipper Transcription FactorsDNABasic-Leucine Zipper Transcription FactorsDNANF-E2-Related Factor 2

Identifiers

PMID36454022
PMCPMC9756947
OpenAlexW4310565651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.